PPIA and Alzheimer disease: Other potential therapeutics include specific inhibitors and genetic manipulation of cyclophilin A (CypA) which can ameliorate the vascular and neuronal dysfunction found in AD model mice through inhibition of the CypA — nuclear factor kappa B (NF-κB) — matrix metalloproteinases-9 pathway [137, 138].